Patent US4225671A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4225671A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the in-vitro biosynthesis of hormones, especially insulin

Assignee: Battelle-Institut
•
Filing: 1978-06-09
•
Granted: 1980-09-30
•
Expires: 1998-06-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Process for the in-vitro biosynthesis of hormones, especially of insulin, by in-vitro conservation or in-vitro propagation of cells from organs and tissues of animal or human origin under suitable cell growth and cell conservation conditions and isolation of the substance formed in a known manner from the culture medium or by processing of the cells. The hormone-producing cells are propagated or conserved in one or more cell culture spaces separated by semipermeable flat membranes of at least one culture medium space.

Inventors

  • 👤 Herwig Puchinger
  • 👤 Ulrich Mueller
  • 👤 Manfred Sernetz

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 19:23
CPC Classifications
C; C12; C12M; C12M23/00; C12M23/34; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/62; C12M29/00; C12M29/04; Y; Y10; Y10S; Y10S435/00; Y10S435/813

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 228 words
Process for the in-vitro biosynthesis of a hormone comprising the steps of (a) introducing (i) cells from organs or tissues of animal or human origin into one or more cell culture spaces and (ii) culture medium separately into one or more culture medium spaces, each cell culture space having a flat top and flat bottom, each culture medium space having a flat top and a flat bottom, when more than one culture medium space and more than one cell culture space are used, the culture medium spaces are in alternating relationship to the cell culture spaces, the culture medium spaces are adjacent to the cell culture spaces, and a culture medium space is located on top of each cell culture space, when one culture medium space and one cell culture space are present, the culture medium space is located adjacent to and on top of the cell culture space, and each culture medium space is separated from each adjacent cell culture space or spaces by a semi-permeable flat membrane which is permeable to liquid and is impermeable to cells, (b) propogating or cultivating in vitro the cells under suitable cell growth or cell cultivation conditions, respectively, whereby the cells in vitro biosynthesize the hormone, and (c) isolating the resultant hormone from the culture medium and/or by processing the cells after removing the cells from the cell culture space.
Claim 2
Dependent Claim 228 words
Process for the in-vitro biosynthesis of a hormone comprising the steps of (a) introducing (i) cells from organs or tissues of animal or human origin into one or more cell culture spaces and (ii) culture medium separately into one or more culture medium spaces, each cell culture space having a flat top and flat bottom, each culture medium space having a flat top and a flat bottom, when more than one culture medium space and more than one cell culture space are used, the culture medium spaces are in alternating relationship to the cell culture spaces, the culture medium spaces are adjacent to the cell culture spaces, and a culture medium space is located on top of each cell culture space, when one culture medium space and one cell culture space are present, the culture medium space is located adjacent to and on top of the cell culture space, and each culture medium space is separated from each adjacent cell culture space or spaces by a semi-permeable flat membrane which is permeable to liquid and is impermeable to cells, (b) propogating or cultivating in vitro the cells under suitable cell growth or cell cultivation conditions, respectively, whereby the cells in vitro biosynthesize the hormone, and (c) isolating the resultant hormone from the culture medium and/or by processing the cells after removing the cells from the cell culture space.
Claim 3
Dependent Claim 41 words
Process as claimed in claim 1 wherein the culture medium is in a circulation system and is repeatedly conducted into the culture medium space, the circulation system having a culture medium supply container, measurement and control equipment and optionally an oxygenator.
Claim 4
Dependent Claim 33 words
Process as claimed in claim 1 wherein the culture medium, in a continuous flowthrough system, is conducted once into the culture medium spaces in order to obtain the substances released via the membranes.
Claim 5
Dependent Claim 49 words
Process as claimed in claim 1 wherein, when more than one culture medium space and more than one cell culture space are used, each cell culture space is separated from the culture medium spaces by semipermeable flat membranes located on top of and below each such cell culture space.
Claim 6
Dependent Claim 30 words
Process as claimed in claim 1 wherein the cell culture spaces are separated by semipermeable flat membranes on top from a culture medium space and below from a gas space.
Claim 7
Dependent Claim 23 words
Process as claimed in claim 1 wherein the semipermeable flat membranes are permeable to molecules having a molecular weight of up to 100,000.
Claim 8
Dependent Claim 19 words
Process as claimed in claim 1 wherein the semipermeable flat membranes have a thickness of 10 to 150 μm.
Claim 9
Dependent Claim 28 words
Process as claimed in claim 1 wherein the semipermeable flat membranes are made of cellulose, a cellulose derivative, a polypeptide, a polyamide, a polysulfone or a polyacrylic nitrile.
Claim 10
Dependent Claim 16 words
Process as claimed in claim 1 wherein the hormone that is biosynthesized in vitro is insulin.
Claim 11
Dependent Claim 20 words
Process as claimed in claim 1 wherein the thickness of each semipermeable flat membrane is from 30 to 100 μm.
Claim 12
Dependent Claim 17 words
Process as claimed in claim 1 wherein the distance between the semipermeable flat membranes is 2 mm.
Claim 13
Dependent Claim 48 words
Process as claimed in claim 1 wherein, added blood serum is present in the culture medium in the culture medium in the culture medium spaces in an amount of 0.5 percent by weight for less based on the weight of the culture medium in the culture medium spaces.

References Cited (Backward Citations)

US3873423A Cited
US3821087A Cited
US3948732A Cited
US4082613A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-09-30 1984-03-31 1984-09-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-09-30 1988-03-31 1988-09-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-09-30 1992-03-31 1992-09-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag